WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 August 2020 Intravenous Fibrinolysis for Central Retinal Artery OcclusionTicagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIASafety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 July 2020 Intravenous Fibrinolysis for Central Retinal Artery Occlusion
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 June 2020 Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral AnticoagulantInitial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMANComparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 May 2020 Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort studyEndovascular Thrombectomy with or without Intravenous Alteplase in Acute StrokeEffect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 April 2020 Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral HemorrhageApixaban for the Treatment of Venous Thromboembolism Associated with CancerDabigatran Treatment of Acute Noncardioembolic Ischemic StrokeOff-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 March 2020 Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic StrokeOptimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging SelectionEfficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trialClinical Risk Factors in Thrombolysis therapy: Telestroke Versus NontelestrokeCoffee Consumption and Risk of Stroke: A Mendelian Randomization Study
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 February 2020 Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes A Secondary Analysis of the COMPASS TrialRivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseStenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis
WHAT WE’RE READING – JOURNAL CLUB January 12, 2021 January 2020 Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNEJM 2019 LDL Targets and Stroke TST TrialOutcome of endovascular therapy in stroke with large vessel occlusion and mild symptomsWhy Most Acute Stroke Studies Are Positive in Animals but Not in Patients: A Systematic Comparison of Preclinical, Early Phase, and Phase 3 Clinical Trials of Neuroprotective AgentsSafety and efficacy of dual antiplatelet pretreatment in ischemic stroke patients treated with IV thrombolysisPublic Health and Cost Benefits of Successful Reperfusion After Thrombectomy for Stroke
WHAT WE’RE READING – JOURNAL CLUB December 16, 2020 Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease
WHAT WE’RE READING – JOURNAL CLUB December 10, 2019March 19, 2020 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic StrokeDOI: 10.1161/STR.0000000000000211
